Zhejiang Hisun Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 0.01%

Zhejiang Hisun Pharmaceutical Co Ltd (600267) has an Asset Resilience Ratio of 0.01% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥1.99 Million

≈ $291.15K USD Cash + Short-term Investments

Total Assets

CN¥13.81 Billion

≈ $2.02 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2000–2025)

This chart shows how Zhejiang Hisun Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Check strategic asset allocation of Zhejiang Hisun Pharmaceutical Co Ltd to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Zhejiang Hisun Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 600267 company net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.99 Million	0.01%
Total Liquid Assets	CN¥1.99 Million	0.01%

Asset Resilience Insights

Limited Liquidity: Zhejiang Hisun Pharmaceutical Co Ltd maintains only 0.01% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Zhejiang Hisun Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Zhejiang Hisun Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Bide Pharmatech Co. Ltd. A SHG:688073	Drug Manufacturers - Specialty & Generic	9.46%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Tianjin Zhongxin Pharmaceutical Group Corp Ltd SHG:600329	Drug Manufacturers - Specialty & Generic	5.92%
Chengdu Kanghong Pharmaceuticals Group Co Ltd SHE:002773	Drug Manufacturers - Specialty & Generic	4.31%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%
Zhejiang Tianyu Pharmaceutical Co Ltd SHE:300702	Drug Manufacturers - Specialty & Generic	0.00%
Zhejiang Anglikang Pharmaceutical Co Ltd Class A SHE:002940	Drug Manufacturers - Specialty & Generic	9.11%

Annual Asset Resilience Ratio for Zhejiang Hisun Pharmaceutical Co Ltd (2000–2025)

The table below shows the annual Asset Resilience Ratio data for Zhejiang Hisun Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	0.02%	CN¥2.37 Million ≈ $346.83K	CN¥15.05 Billion ≈ $2.20 Billion	+0.01pp
2023-12-31	0.00%	CN¥292.62K ≈ $42.82K	CN¥17.61 Billion ≈ $2.58 Billion	-0.01pp
2021-12-31	0.02%	CN¥3.05 Million ≈ $446.70K	CN¥19.37 Billion ≈ $2.84 Billion	+0.01pp
2020-12-31	0.00%	CN¥357.60K ≈ $52.33K	CN¥20.86 Billion ≈ $3.05 Billion	-1.14pp
2017-12-31	1.14%	CN¥246.00 Million ≈ $36.00 Million	CN¥21.64 Billion ≈ $3.17 Billion	-0.31pp
2016-12-31	1.45%	CN¥300.00 Million ≈ $43.90 Million	CN¥20.76 Billion ≈ $3.04 Billion	-2.18pp
2015-12-31	3.62%	CN¥695.00 Million ≈ $101.70 Million	CN¥19.17 Billion ≈ $2.81 Billion	+3.62pp
2014-12-31	0.00%	CN¥225.50K ≈ $33.00K	CN¥17.30 Billion ≈ $2.53 Billion	0.00pp
2009-12-31	0.00%	CN¥71.40K ≈ $10.45K	CN¥5.20 Billion ≈ $760.73 Million	-4.94pp
2001-12-31	4.94%	CN¥64.12 Million ≈ $9.38 Million	CN¥1.30 Billion ≈ $190.07 Million	-2.93pp
2000-12-31	7.86%	CN¥94.90 Million ≈ $13.89 Million	CN¥1.21 Billion ≈ $176.61 Million	--

pp = percentage points

About Zhejiang Hisun Pharmaceutical Co Ltd

SHG:600267 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.12 Billion

CN¥14.46 Billion CNY

Market Cap Rank

#5924 Global

#1099 in China

Share Price

CN¥12.06

Change (1 day)

-3.37%

52-Week Range

CN¥9.48 - CN¥12.48

All Time High

CN¥20.23